Home Blog Page 2778

Antengene’s ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma

By
Advertorial Desk
-

SHANGHAI and HONG KONG, Aug. 19, 2025 /PRNewswire/ — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematologic malignancies and solid tumors, today announced that its in-house discovered CLDN18.2 ADC, ATG-022,was granted a Breakthrough Therapy designation by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for the treatment of CLDN18.2-positive, HER-2 negative unresectable or metastatic gastric or gastroesophageal junction (GC/GEJ) in patients who have received at least two prior lines of therapy.

To provide further details on the latest clinical data of ATG-022, Antengene’s management team will host a conference call on August 20, 2025 (Wednesday), from 9:00 am to 10:00 am (Beijing Time). 

Ways to Participate: 

1. Webcast: https://s.comein.cn/5hgdc8k2

2. Conference Call:
(Dial-in From China)
Mainland of China: +86-4001510269
Global: +86-01021377168
(Dial-in From Overseas)
Hong Kong, China: +852-51089680
Hong Kong, China: +852-800931266
Taiwan, China: +886-277083288
Global: +86-01021377168
United States: +1-2087016888
Access Code: 303021

Management Participants:

Dr. Jay Mei
Founder, Chairman, and CEO
Mr. Donald Lung
Chief Financial Officer
Mr. Kavin Cao 
Corporate Vice President and Board Secretary
Dr. Bing Hou
Vice President, Head of Discovery Science and Translational Medicine
Dr. Godfrey Guo
Vice President, Clinical Development

The Breakthrough Therapy designation, introduced by the NMPA, is a key initiative aimed at accelerating the development and approval of innovative medicines that offer significant clinical benefits. With this designation, ATG-022 will receive priority review resources, reducing the overall research and development timeline and enabling faster access for patients in China. This follows the U.S. Food and Drug Administration’s (FDA) granting of Orphan Drug Designation (ODD) to ATG-022 for the treatment of gastric and pancreatic cancers, highlighting its strong clinical potential across multiple tumor types.

In the ongoing CLINCH Phase I/II clinical study, data show that ATG-022 demonstrated significant antitumor activity and a favorable safety profile in patients with gastric or gastroesophageal junction adenocarcinoma across high, low, and ultra-low CLDN18.2 expression levels.

  • CLDN18.2 Moderate-to-high expression (IHC 2+ > 20%)
    • 2.4 mg/kg Cohort
    • Objective Response Rate (ORR): 40% (12/30), including 1 Complete Response (CR)
    • Disease Control Rate (DCR): 90% (27/30)
    • Median Progression-free Survival (mPFS): 6.97 months
    • 6-month PFS Rate: 51.1%
    • 9-month Overall Survival (OS) Rate: 82.7%
    • 12-month OS Rate: 66.2%
       
    • 1.8 mg/kg Cohort
    • ORR: 40% (10/25), including 1 CR
    • DCR: 84% (21/25)
  • CLDN18.2 Low and Ultra-low expression (IHC 2+ ≤ 20%)
    • Efficacious dose range of 1.8-2.4 mg/kg
    • ORR: 33.3% (6/18), including 1 CR
    • DCR: 50% (9/18)
    • Notably, some responding patients had CLDN18.2 expression levels below 5%, underscoring the robust antitumor activity of ATG-022 in both low- and ultra-low-expression populations.

To date, three patients in the study have achieved CR during treatment, with one case observed in each of the three aforementioned cohorts (i.e., both dose levels in the CLDN18.2 moderate-to-high expressor cohorts and the CLDN18.2 low and ultra-low expressor cohort). This broad-spectrum antitumor activity positions ATG-022 as a potential new treatment option for a wider patient population compared with other CLDN18.2-targeted therapies.

Antengene is currently conducting the Phase II dose-expansion stage of ATG-022 in the Mainland of China and Australia, with the program now entering mid-to-late stage of clinical validation. The company will continue to advance the clinical development of ATG-022 in gastric cancer while exploring its potential in other CLDN18.2-positive tumors. For gastric cancer indications, the development strategy spans first- through third-line treatment:

  • First-line treatment (CLDN18.2 IHC 1+ ≥1%, PD-L1 CPS ≥1%): ATG-022 in combination with pembrolizumab and chemotherapy (CAPOX/FOLFOX)
  • Second-line treatment (CLDN18.2 IHC 1+ ≥1%, PD-L1 CPS ≥1%): ATG-022 in combination with pembrolizumab
  • Third-line treatment (CLDN18.2 IHC 2+): ATG-022 monotherapy, covering patients across different CLDN18.2 expression levels, including CLDN18.2 moderate-to-high expressor (2+ >20%), and low and ultra-low expressors (2+ ≤20%)

In addition, the ongoing Phase II study includes a basket trial cohort covering multiple tumor types. In a certain subtype of gynecologic tumor, all 7 patients who had undergone at least one efficacy assessment demonstrated tumor shrinkage, indicating significant clinical potential for ATG-022 in other CLDN18.2-positive tumors. This cohort remains open for enrollment and follow-up, and the continued data generation is expected to further strengthen the robust value proposition of ATG-022 across multiple tumor types.

About Antengene
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a global, R&D-driven, commercial-stage biotech company focused on developing first-in-class/best-in-class therapeutics for diseases with significant unmet medical needs. Its pipeline spans from preclinical to commercial stages and includes several in-house discovered programs, including ATG-022 (CLDN18.2 ADC), ATG-037 (oral CD73 inhibitor), ATG-101 (PD-L1 × 4-1BB bispecific antibody), ATG-031 (CD24-targeting macrophage activator), and ATG-042 (oral PRMT5-MTA inhibitor).

Antengene has also developed AnTenGager™, a proprietary T cell engager 2.0 platform featuring “2+1” bivalent binding for low-expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to minimize cytokine release syndrome (CRS) and enhance efficacy. These characteristics support the platform’s broad applicability across autoimmune disease, solid tumors and hematological malignancies indications.

To date, Antengene has obtained 31 investigational new drug (IND) approvals in the U.S. and Asia, and submitted new drug applications (NDAs) in 11 Asia Pacific markets. Its lead commercial asset, XPOVIO® (selinexor), is approved in the Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia.

Forward-looking statements
The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. For a further discussion of these and other factors that could cause future results to differ materially from any forward-looking statement, please see the other risks and uncertainties described in the Company’s Annual Report for the year ended December 31, 2024, and the documents subsequently submitted to the Hong Kong Stock Exchange.

 

CIMB Singapore Launches CIMB FlexiPay: A First-of-its-kind, Revenue-Based Loan for SMEs

By
Advertorial Desk
-

It aims to empower SMEs with a fully digital, revenue-based loan that adapts to daily cash flow.

SINGAPORE, Aug. 19, 2025 /PRNewswire/ — CIMB Singapore today announced the launch of CIMB FlexiPay – an innovative “pay-as-you-earn” loan designed to support small and medium-sized enterprises (SMEs) with smarter, flexible access to financing.

The first of its kind in Singapore, CIMB FlexiPay links repayments directly to a business’ daily revenue. On days with no revenue, no repayment is required. This fully digital solution is designed to ease cash flow pressures while removing the traditional barriers SMEs face in securing financing.

Addressing SMEs’ Biggest Pain Point: Cash Flow

SMEs remain one of the most underserved segments in banking. Many of them struggle with seasonal, irregular or unpredictable income, making monthly repayments a challenge. CIMB FlexiPay addresses this gap with a loan that adjusts to a company’s performance, ensuring businesses repay only when they earn.

Key Features of CIMB FlexiPay

  • Revenue-linked repayments: Automatically deducted from daily deposits based on a business’ selected holdback rate*. For example, if the selected holdback rate* is 5% and the business earns S$1,000 in a day, S$50 will be repaid that day. On days with no revenue, no repayment is required.
  • Management with full certainty and transparency: Pay a single upfront fee – no interest, no prepayment fees, and no late fees.
  • Fully digital process: No physical forms or document submissions required. Customers can accept loan offers digitally.

“With CIMB FlexiPay’s pay-as-you-earn structure, SMEs gain flexibility, transparency and control in managing their financing. This innovation reflects our commitment to rethinking traditional banking and supporting businesses with solutions that truly adapt to their cash flow realities,” said Benjamin Tan, Head of Commercial & Transaction Banking, CIMB Singapore. “By removing traditional barriers and offering a seamless digital experience, we aim to help businesses grow with confidence.”

For more information or to apply, visit CIMB FlexiPay.

Terms & Conditions apply.

*Holdback rate is the percentage of the business’ daily revenue that will go towards repaying CIMB FlexiPay. 

Disclaimer:

Deposit Insurance Scheme

Singapore dollar deposits of non-bank depositors are insured by the Singapore Deposit Insurance Corporation, for up to S$100,000 in aggregate per depositor per Scheme member by law. Foreign currency deposits, dual currency investments, structured deposits and other investment products are not insured. 

About CIMB

CIMB is one of ASEAN’s leading banking groups and Malaysia’s second largest financial services provider, by assets. Listed on Bursa Malaysia via CIMB Group Holdings Berhad, it had a market capitalisation of approximately RM75.2 billion as at 31 March 2025. It offers consumer banking, commercial banking, wholesale banking, transaction banking, Islamic banking and asset management products and services. Headquartered in Kuala Lumpur, the Group is present across ASEAN in Malaysia, Indonesia, Singapore, Thailand, Cambodia, Vietnam and Philippines. Singapore is one of its key markets with approximately 1,000 employees serving clients across consumer, commercial, wholesale and transaction banking products and services.

Beyond ASEAN, the Group has market presence in Mainland China, Hong Kong and UK. CIMB has one of the most extensive retail branch networks in ASEAN with 592 branches and over 33,000 employees as at 31 March 2025. CIMB’s investment banking arm is one of the largest Asia Pacific-based investment banks, which together with its award-winning treasury & markets and corporate banking units comprise the Group’s leading wholesale banking franchise. CIMB is also the 92.5% shareholder of Bank CIMB Niaga in Indonesia, and 94.8% shareholder of CIMB Thai in Thailand.

Sustainability is a core pillar of CIMB’s Forward30 strategy and 2030 roadmap. The Group is guided by its Green, Social, Sustainable Impact Products and Services (“GSSIPS”) framework, an internal taxonomy designed to deliver impactful sustainable finance. Since launching its sustainable finance framework in 2021, CIMB has progressively raised its ambitions, increasing its initial RM30 billion target to RM100 billion for 2021–2024. The Group now targets RM300 billion in sustainable finance by 2030, reinforcing its commitment to enabling a lower-carbon and more inclusive economy across the region.

 

GemW Launches Partner Program: Empowering Creators with Alpha Strategies and Long-Term Value

By
Advertorial Desk
-

SINGAPORE, Aug. 19, 2025 /PRNewswire/ — GemW, an intelligent trading platform developed by the global leading digital asset exchange CoinW, has officially launched the GemW Partner Program. Designed for strategy creators, KOLs, and professional traders, the program provides powerful strategy tools, content exposure, and revenue-sharing opportunities. Its goal is to help creators establish their own Alpha strategy dashboard, amplify their expertise, and achieve long-term monetization.

GemW Partner Program
GemW Partner Program

In an increasingly complex DeFi landscape and rapidly evolving multi-chain ecosystems, the GemW Partner Program introduces a new paradigm built on three pillars: lowering the barrier to creation, enhancing operational efficiency, and offering diverse incentive mechanisms. This toolkit empowers trading-focused creators with the infrastructure needed to drive growth and value in a content-driven, decentralized financial ecosystem.

Meet GemW: Built for Traders, Designed for Creators

GemW offers creators and their communities a complete solution that combines tools, incentives, and influence:

  • For users: Instantly follow and copy high-quality strategies, receiving real-time trading signals.
  • For creators: Publish strategies, grow a loyal following, and earn commissions through transparent knowledge monetization.
  • For all participants: CoinW’s custodial security infrastructure and MEV protection ensure a stable and transparent trading environment.

Currently supporting the Solana mainnet, GemW will soon expand to BSC, Base, and other ecosystems, broadening the reach of strategies and creator communities across multiple chains.

Empowering Growth Through the Partner Program

At its core, the GemW Partner Program is built to empower early-stage strategy creators and foster a creator-driven trading ecosystem. Beyond tools and exposure, the program includes tailored incentive mechanisms to help creators build engaged communities around their strategies.

By sharing strategies and professional insights, partners receive performance-based rewards while enabling users to make smarter, faster decisions in volatile on-chain markets.

“GemW is more than a trading platform—it’s a creator-centered ecosystem,” the GemW team noted. “Our Partner Program provides contributors with the tools to expand their influence, monetize their expertise, and build loyal communities.”

Exclusive Benefits for GemW Partners

  • Official recognition & tools: “GemW Partner” badge, strategy pools, growth leaderboards, and copy-trade analytics to enhance influence and engagement.
  • Competitive income and rewards: Up to 50% revenue sharing, real-time settlement, and a dual-layer system including commissions and exclusive airdrops.
  • Transparency & exposure: Public performance dashboards, access to reward pools, and participation in AMAs and co-created content.
  • Priority visibility: Homepage features, social media promotion, and exclusive fan rewards to grow reach and strengthen communities.
  • Early partner perks: Special badges, early access to new features, community support, and regional leadership roles.

Together, it provides a welcome boost for partners to build engaged communities and maximize their impact on GemW’s growing platform. The added visibility likewise helps build influence and increase their earnings within the GemW ecosystem.

Unlock the Power of GemW
Unlock the Power of GemW

Upgraded Incentives to Drive Long-Term Growth

To further empower partners in community building and monetization, GemW offers a suite of targeted incentives:

  • User growth bonus: Earn 10 USDT for each successful referral.
  • Performance rewards: Top-performing partners can access event kits worth up to 2,000 USDT for hosting trading challenges and campaigns.
  • Elite partner support: Tailored growth initiatives, joint branding opportunities, and full official backing.

Upcoming features such as real-time copy-trade data, automated commission systems, performance leaderboards, and subscription models will further extend partner reach and unlock sustainable growth.

Looking Ahead: Expanding the Ecosystem

The GemW Partner Program will continue to evolve, with upcoming tools designed to enhance strategy monetization and community engagement. These include real-time strategy updates, automated revenue distribution, and subscription-based features.

Interested in joining? Apply now to become a GemW Partner and build your own Alpha strategy dashboard in a transparent, creator-driven ecosystem.

Discover GemW—identify true potential tokens and capture real trading opportunities.

About GemW

GemW is an intelligent trading platform launched by CoinW team to simplify access to early-stage on-chain assets and trending meme tokens. As a user-friendly on-chain trading platform, GemW is designed to make decentralized trading simpler, smarter, and more accessible. With no wallet setup or gas fees required, it offers a seamless experience backed by institutional-grade custody and MEV protection. The platform features curated token opportunities, live strategies from top KOLs, Smart Money tracking, and one-click copy trading. Users benefit from advanced automation tools, transparent analytics, and performance-based rebates—empowering both traders and creators to thrive in a dynamic, community-driven ecosystem.

Fujitsu signs new licensing agreement with Palantir

By
Advertorial Desk
-

Strengthened partnership to drive generative AI adoption and innovation for enterprises

KAWASAKI, Japan, Aug. 19, 2025 /PRNewswire/ — Fujitsu today announced the signing of a new licensing agreement with Palantir Technologies Japan for the Palantir Artificial Intelligence Platform (Palantir AIP), a software that supports the integration of generative AI into business operations. The agreement, signed on August 5, 2025, will allow Fujitsu to provide Palantir AIP to its customers in Japan, with global expansion expected during fiscal 2025. Fujitsu will also combine Palantir AIP with Fujitsu Uvance, its business model to solve societal issues, to facilitate business transformation for its customers in Japan and around the world. This agreement will further strengthen the strategic global partnership between Fujitsu and Palantir.

Fujitsu and Palantir began their collaboration in 2020, focusing on data integration and digital transformation support in the Japanese market. In 2023, the two parties signed a global agreement, under which Palantir grants Fujitsu the right to market and distribute Palantir Foundry, a platform currently offered for integrated management of large-scale data dispersed across various systems.

When combined with Palantir Foundry, Palantir AIP enables the rapid implementation of generative AI functionalities for data analysis and decision-making within enterprises. It can be used with a preferred large language model (LLM) within corporate networks and is adopted extensively in highly confidential sectors such as finance and defense. By leveraging Palantir AIP, customers can design and develop systems utilizing generative AI and AI agents in a fraction of the time of conventional methods, enabling faster optimization of supply chains, automation of business workflows, and to empower executive decision-making.

Fujitsu currently offers solutions that combine its operational expertise with Palantir Foundry for data integration and analysis, optimizing operations in areas such as supply chain and engineering. The integration of Palantir AIP into Fujitsu Uvance will introduce unified support for generative and agentic AI tasks including scenario simulation, root cause analysis, and proposal generation and further optimize business processes. Furthermore, by linking with Fujitsu’s AI services such as Takane and Fujitsu Kozuchi, Fujitsu will enhance Japanese language capabilities and business-specific functionalities, and facilitate the rapid implementation of agentic AI for customers with Japanese language requirements. This will contribute to the realization of data-driven autonomous decision-making workflows that transcend traditional visualization-centric analyses while retaining the indispensable oversight and expertise of human practitioners.

For full release click here

 

SSSTC Launches World’s First Industrial M.2 SSD Featuring KIOXIA’s 8th generation BiCS FLASH™ Technology and PCIe® 5.0 Interface

By
Advertorial Desk
-

TAIPEI, TAIWAN – Media OutReach Newswire – 19 August 2025 – Solid State Storage Technology Corporation (SSSTC) proudly announces the launch of the SSSTC CA8 Series, the world’s first industrial M.2 SSD built with BiCS FLASH™ generation 8 3D flash memory technology and a PCIe® Gen5 x4 interface. Offered in the industry-standard M.2 2280 form factor, the SSSTC CA8 Series is available in 512 GB, 1 TB, 2 TB, and 4 TB capacities.

The SSSTC CA8 Series is the world’s first industrial M.2 SSD to combine KIOXIA’s 8th-generation BiCS FLASH™ 3D NAND technology with PCIe Gen5 x4 interface, image credit SSSTC.
The SSSTC CA8 Series is the world’s first industrial M.2 SSD to combine KIOXIA’s 8th-generation BiCS FLASH™ 3D NAND technology with PCIe Gen5 x4 interface, image credit SSSTC.

The SSSTC CA8 Series complies with PCIe® 5.0 and NVMe™ 2.0, supporting ultra-high-speed data access with transfer rates up to 32 GT/s per-lane—doubling the throughput of PCIe® 4.0 interface. With SLC caching, the SSSTC CA8 Series achieves sequential read speeds of up to 14,000 MB/s and write speeds up to 12,000 MB/s, along with random performance of up to 2,000K IOPS (read) and 1,600K IOPS (write) — making it one of the fastest industrial SSDs on the market.

At its core is KIOXIA’s 8th generation BiCS FLASH™ 218-layer 3D TLC NAND Flash Memory with CMOS directly Bonded to Array (CBA) wafer bonding technology , enabling a 20% improvement in write performance, over 10% reduction in read latency, and up to 30% better power consumption. These enhancements make the SSSTC CA8 Series a critical enabler for data-intensive edge computing and high-performance industrial workloads.

Designed for long-term reliability and broad system compatibility, the SSSTC CA8 Series features:
• MTBF exceeding 3 million hours
• Wide operating temperature range (0 °C to 85 °C)
• Supply longevity of 5 to 10 years

Its robust durability and consistent performance make it ideal for demanding applications such as AIoT, factory automation, networking, in-vehicle systems, and edge servers—especially those involving Edge AI workloads.

To ensure data integrity and system resilience, the CA8 Series includes:
• High-performance ECC
• Power Loss Notification (PLN) to prevent data corruption during unexpected shutdowns
• AES-256 encryption and TCG Opal support for advanced data protection

As a subsidiary of KIOXIA, SSSTC is committed to delivering highly stable, high-performance SSD solutions to global enterprise and industrial customers. The SSSTC CA8 Series is scheduled to enter mass production in Q4 2025. For more information, please visit the SSSTC website

Hashtag: #SSSTC

The issuer is solely responsible for the content of this announcement.

About Solid State Storage Technology Corporation (SSSTC)

SSSTC, a subsidiary of KIOXIA—one of the world’s leading memory solution providers—is dedicated to the development, manufacturing, and sales of solid-state drives (SSDs). By combining its in-house R&D capabilities with KIOXIA’s cutting-edge NAND flash technology, SSSTC consistently delivers high-quality, high-reliability industrial-grade and enterprise-grade SSD solutions to customers worldwide.

Trademark Notice:
-NVMe is a registered or unregistered trademarks of NVM Express, Inc. in the United States and other countries.
-PCIe is a registered trademark of PCI-SIG.
-Other company names, product names and service names may be trademarks of third-party companies.

Pinnacle Mastery Institute Launches “The Pinnacle” Leadership and Transformation Programme

By
Advertorial Desk
-

Three-day intensive with follow-up practice sessions designed to help participants explore systemic dynamics and leadership challenges.

SINGAPORE – Media OutReach Newswire – 19 August 2025 – Pinnacle Mastery Institute, a Singapore-based training and development organisation, today announced the launch of The Pinnacle, a new programme created by founder Hun Ming Kwang. The programme is designed to help individuals strengthen their leadership capacity, tackle systemic challenges, and navigate personal and professional transitions with greater clarity.

The Pinnacle begins with a three-day in-person intensive and continues with five weeks of evening practice sessions. Participants undertake a 28-day project to apply the insights and methods learned, ensuring that the programme’s outcomes are grounded in practical action.

Drawing on process-oriented psychology and systemic constellations, the programme explores how unseen dynamics – such as unspoken group roles, family patterns, and internal conflicts – shape behaviour and decision-making. The structure is designed to help participants work through recurring challenges, access overlooked strengths, and realign with long-term goals.

“This programme is about creating the conditions for deeper reflection and integration,” said Hun Ming Kwang, founder of Pinnacle Mastery Institute. “Our aim is not to provide quick solutions but to equip participants with tools and perspectives they can carry forward into their leadership and personal lives.”

Key areas of focus in The Pinnacle include:

  • Balancing independence with collaboration and support
  • Understanding systemic influences in families, organisations, and teams
  • Identifying “ghost roles” – hidden forces that shape dynamics and outcomes
  • Interpreting body signals as sources of insight and guidance

The Pinnacle is intended for professionals, entrepreneurs, and changemakers who want to expand their leadership practice and navigate complex environments with greater resilience and coherence.

To learn more or register for the upcoming cohort of The Pinnacle, visit: https://www.hunmingkwang.com/

Hashtag: #PinnacleMasteryInstitute





The issuer is solely responsible for the content of this announcement.

About Pinnacle Mastery Institute

Pinnacle Mastery Institute is a Singapore-based organisation dedicated to leadership, systemic awareness, and personal development. Through its programmes and workshops, the institute integrates psychological depth with practical application, supporting individuals and organisations in building clarity, resilience, and impact.

About Hun Ming Kwang

Hun Ming Kwang is the founder of Pinnacle Mastery Institute and a facilitator specialising in inner work and leadership development. He has led programmes and initiatives in Singapore and internationally, with participants from diverse professional and community backgrounds.

Introducing Miutine, the new irreverent, fragrance by Miu Miu

By
Advertorial Desk
-

PARIS, Aug. 19, 2025 /PRNewswire/ — Miu Miu unveils Miutine, the new feminine fragrance, capturing the ultimate essence of the Miu Miu woman, irreverent, youthful in spirit, and unconventional. Miutine is worn entirely for oneself away from any gaze. Captured in a toffee-toned matelassé flacon, the scent within, a classic chypre signature, is twisted with a fruity gourmet cheekiness. 

To view the Multimedia News Release, please click:
https://www.multivu.com/miu-miu-beauty/9349051-en-introducing-miutine-new-irreverent-fragrance-by-miu-miu

The name: Miutine

Miutine. A mischievous, Miu Miu twist on the French ‘mutine’, a rebel’s spirit, bottled. The spirit of the Miu Miu girl: irreverent. She knows the rules and enjoys twisting them. Miutine is not a statement, but a knowing glance. A sweet rebellion, light-hearted and laced with wit, a gesture made for oneself. 

“The composition invites self-affirmation and confidence, creating a perfume for oneself away from any gaze. This colorful and modern composition captures the essence of the Miu Miu girl” Dominique Ropion, Master Perfumer.  

The juice: An irreverent, explosive gourmet

Imagined by master perfumer Dominique Ropion, Miutine is a twist of the codes, a gourmet cheekiness rendered in fragrance. Inspired by a timeless classic of women’s perfumery – the Chypre family – Miutine is characterized by a sophisticated blend of bright citrus, a floral heart, and a rich, earthy base of oakmoss and patchouli. This iconic chypre structure is subverted by a daring duo of wild strawberry and brown sugar accords, possessing a chypre signature, gourmand, intimate, and enveloping.  

The bottle: A tribute to the Miu Miu matelassé

The bottle echoes Miu Miu’s most iconic codes. The recognizable black and white label becomes a desirable collar, on a beautifully crafted Matelassé glass. A tribute to the iconic matelassé leather of the Miu Miu house.

The ambassador: An irreverent multi-awarded voice

Miu Miu’s ambassador, Golden Globe-winning actor Emma Corrin, perfectly embodies the Miutine spirit through constant transformation, effortless, wit, and boldness. They are a person perpetually recreating themselves for their own evolution, representing an irreverent multi-awarded voice.

“The scent represents all the aspects that I treasure and respect the most in myself and others; rebellion, expression, originality. It’s one for the free spirits” – Emma Corrin, Global Ambassador.

Directed by longtime friend of the House, Sundance Jury Prize winner, filmmaker Hailey Benton Gates, the Miutine campaign will debut on 20 August 2025. What – or who – is Miutine? The campaign is a definition of the Miutine spirit in motion.

 

Introducing Miutine, the new irreverent, fragrance by Miu Miu

 

Video – https://mma.prnasia.com/media2/2742991/Miu_Miu_Beauty.mp4

Digital Asset Anti-Money Laundering Council (DAAMC) Launched with Support from the Hong Kong Virtual Assets Industry Association (HKVAIA) to Strengthen Stablecoin Compliance and Financial Integrity

By
Advertorial Desk
-

HONG KONG, Aug. 19, 2025 /PRNewswire/ — The Digital Asset Anti-Money Laundering Council (DAAMC), a groundbreaking, industry-led nonprofit organization supported by the Hong Kong Virtual Assets Industry Association (HKVAIA), proudly announces its launch. DAAMC is dedicated to promoting compliant stablecoin issuance and enhancing financial integrity in Hong Kong’s digital asset ecosystem through collaboration among regulated financial institutions to develop and promote best-in-class Anti-Money Laundering and Counter-Financing of Terrorism (AML/CFT) standards and practices.

DAAMC responds to the Hong Kong Monetary Authority’s (HKMA) Guideline on Anti-Money Laundering and Counter-Financing of Terrorism (For Licensed Stablecoin Issuers) and explores emerging global industry compliance standards, such as on-chain identity verification, to ensure Hong Kong’s regulated stablecoins achieve mainstream adoption by balancing risk control with sustainable business development.

The Council, initiated by four leading organizations with diverse expertise, is committed to shaping the future of digital finance in Hong Kong, focusing on stablecoin innovation and compliance: 

  • HashKey Group: A leading digital asset financial services group in Asia with global operations. Its subsidiary, HashKey Exchange, is the licensed virtual asset exchange in Hong Kong, holding Type 1, Type 7, and AMLO licenses issued by the Hong Kong Securities and Futures Commission.
  • RD InnoTech Limited (a subsidiary of RD Technologies Group): A participant in the HKMA Stablecoin Issuer Sandbox, advancing compliant stablecoin issuance, ecosystem development, and use-case expansion. 
  • Beosin: A leading blockchain security and compliance solutions company specializing in smart contract security audit, AML/CFT tools, and blockchain forensics.
  • SlowMist: A leading blockchain threat intelligence firm, providing services such as security audits, red teaming, AML/CFT solutions, and more.

This diverse coalition reflects DAAMC’s commitment to uniting industry expertise to address the unique AML/CFT challenges of digital assets, including stablecoins, to achieve large-scale adoption and integration with traditional finance. By integrating expertise in digital asset trading, stablecoin innovation, blockchain analytics, and threat intelligence, DAAMC aims to establish a compliant ecosystem, setting a global benchmark for financial integrity in Hong Kong’s stablecoin issuance.

A Strategic Response to Hong Kong’s Stablecoin Ambitions

Hong Kong is solidifying its position as a global leader in digital finance through the government’s Digital Asset Policy Statement 2.0 (June 2025) and the recently effective Stablecoins Ordinance. DAAMC’s establishment aligns with this vision, directly supporting the HKMA’s Guideline on Anti-Money Laundering and Counter-Financing of Terrorism (For Licensed Stablecoin Issuers) to ensure regulated stablecoins comply with global financial standards while promoting innovation. DAAMC actively engages with industry discussions on regulatory strictness, committed to researching and exploring how to balance regulatory requirements with business development, enabling Hong Kong-issued compliant stablecoins to achieve mainstream adoption by regulated institutions and traditional enterprises.

Initiated by founding members HashKey Group, RD InnoTech Limited, Beosin, and SlowMist, DAAMC is dedicated to promoting digital asset industry development and collaboration, through activities such as offline seminars to engage relevant industry stakeholders in exploring innovative compliance solutions for stablecoins. DAAMC will soon release two AML technical reports on stablecoins to provide further industry guidance. At the end of this month, DAAMC will host a seminar, bringing together industry experts to discuss stablecoin compliance and innovation strategies. All industry stakeholders are cordially invited to participate.

DAAMC’s Mission and Impact

DAAMC serves as a central platform for regulated financial institutions—including banks, licensed Virtual Asset Service Providers (VASPs), and future licensed stablecoin issuers—to collaborate on critical initiatives. Led by its founding members, the Council will focus on: 

  • Developing Industry Best Practices: Creating practical guidelines for on-chain identity verification, Travel Rule implementation, risk-based digital asset management, and AML frameworks for Decentralized Finance (DeFi) to ensure compliance aligns with traditional financial standards. 
  • Fostering Regulatory Dialogue: Building trusted communication channels with regulators and law enforcement to shape effective policies that support stablecoin mainstreaming. 
  • Promoting Professional Education: Partnering with academic institutions to elevate AML/CFT expertise tailored to stablecoin issuance and digital asset compliance. 
  • Encouraging Responsible Innovation: Balancing risk control with sustainable business development, ensuring regulated stablecoins thrive in Hong Kong’s compliant ecosystem.

DAAMC welcomes participation from a wide range of stakeholders, including Institutional Members (banks, VASPs, stablecoin issuers), Associate Members (audit firms, legal firms, professional bodies such as ACAMS and HKIB), and Educational Partners. By joining DAAMC, organizations will shape policy, manage risks, and demonstrate a commitment to financial integrity while promoting the mainstream adoption of regulated stablecoins.

A Call to Action

With Hong Kong’s Stablecoins Ordinance taking effect in August 2025, DAAMC’s launch underscores its commitment to driving digital asset industry compliance and integrity through collaborative leadership. DAAMC invites leading industry companies, compliance institutions, and innovative enterprises to join this transformative initiative. 

1...2,7772,7782,779...6,550Page 2,778 of 6,550